Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Pancreatic Inoperable Cancer”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Very early researchEnded earlyNCT03600623
What this trial is testing

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerBorderline Pancreatic Inoperable CancerPancreatic Cancer
University of Alabama at Birmingham 25
Not applicableActive Not RecruitingNCT03621644
What this trial is testing

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Viewray Inc. 133
Testing effectiveness (Phase 2)Ended earlyNCT01359007
What this trial is testing

FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of Pancreas
University of Oklahoma 5
Not applicableNot Yet RecruitingNCT06868693
What this trial is testing

Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer

Who this might be right for
Pancreatic Cancer ResectablePancreatic Cancer Stage IINeoadjuvant Therapy+2 more
Azienda Unita Sanitaria Locale di Piacenza 240
Testing effectiveness (Phase 2)Looking for participantsNCT02598349
What this trial is testing

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Proton Collaborative Group 60